Respiratory Clinical Trials
Description: RCTC conduct studies primarily in patients with respiratory conditions including asthma, COPD (includes emphysema and chronic bronchitis), bronchiectasis, idiopathic pulmonary fibrosis and lung cancer and sleep disorders including insomnia.
asthma (970) copd (300) lung cancer (198) sleep disorders (96) emphysema (42) chronic bronchitis (9) bronchiectasis (9) respiratory conditions (7) idiopathic pulmonary fibrosis (7) rctc (3)
Respiratory Clinical Trials was first established in 1999 (formerly known as Adelaide Respiratory Research then Respiratory Research Foundation) and has conducted more than 80 outpatient (phase II, III and IV) studies and inpatient studies in partnership with pharmaceutical companies.
Due to our competitive ability we have also recruited in other therapeutic areas including a new oral anti-coagulant for use post surgery, a new one-dose Japanese encephalitis vaccine and observational studies including non-cancer, opioid-induced constipation.
Committed to Clinical Research in Respiratory Disease
Respiratory Clinical Trials